- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 235/08 - Radicals containing only hydrogen and carbon atoms
Patent holdings for IPC class C07D 235/08
Total number of patents in this class: 475
10-year publication summary
|
40
|
39
|
33
|
31
|
34
|
30
|
24
|
27
|
9
|
15
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Idemitsu Kosan Co., Ltd. | 4228 |
47 |
| LG Chem, Ltd. | 17926 |
10 |
| Allergan, Inc. | 2170 |
7 |
| Theravance Biopharma R&D IP, LLC | 408 |
7 |
| Glaxosmithkline LLC | 528 |
6 |
| Merck Sharp & Dohme Corp. | 2183 |
6 |
| Merck Patent GmbH | 5725 |
5 |
| The General Hospital Corporation | 4855 |
5 |
| Array BioPharma Inc. | 448 |
5 |
| Vivoryon Therapeutics N.V. | 48 |
5 |
| Janssen Pharmaceutica N.V. | 3175 |
4 |
| Bayer Pharma AG | 1015 |
4 |
| Takeda Pharmaceutical Company Limited | 2713 |
4 |
| Ecolab USA Inc. | 5789 |
4 |
| Ideaya Biosciences, Inc. | 157 |
4 |
| Nippon Shinyaku Co., Ltd. | 322 |
4 |
| The Research Foundation for The State University of New York | 1731 |
4 |
| University of Washington through its Center for Commercialization | 505 |
4 |
| The Royal Institution for The Advancement of Learning / McGill University | 714 |
4 |
| Pharma Cinq, LLC | 69 |
4 |
| Other owners | 332 |